Annual Total Liabilities
$28.04 M
+$7.97 M+39.72%
December 1, 2024
Summary
- As of February 26, 2025, VKTX annual total liabilities is $28.04 million, with the most recent change of +$7.97 million (+39.72%) on December 1, 2024.
- During the last 3 years, VKTX annual total liabilities has risen by +$19.27 million (+219.47%).
- VKTX annual total liabilities is now at all-time high.
Performance
VKTX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$28.04 M
+$1.60 M+6.06%
December 1, 2024
Summary
- As of February 26, 2025, VKTX quarterly total liabilities is $28.04 million, with the most recent change of +$1.60 million (+6.06%) on December 1, 2024.
- Over the past year, VKTX quarterly total liabilities has stayed the same.
- VKTX quarterly total liabilities is now -16.60% below its all-time high of $33.63 million, reached on March 31, 2024.
Performance
VKTX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
VKTX Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +39.7% | 0.0% |
| 3 y3 years | +219.5% | +219.5% |
| 5 y5 years | +292.9% | +292.9% |
VKTX Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +219.5% | -16.6% | +219.5% |
| 5 y | 5-year | at high | +292.9% | -16.6% | +292.9% |
| alltime | all time | at high | >+9999.0% | -16.6% | +3612.3% |
Viking Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $28.04 M(+39.7%) | $28.04 M(+6.1%) |
| Sep 2024 | - | $26.44 M(+2.2%) |
| Jun 2024 | - | $25.86 M(-23.1%) |
| Mar 2024 | - | $33.63 M(+67.5%) |
| Dec 2023 | $20.07 M(-13.5%) | $20.07 M(+39.2%) |
| Sep 2023 | - | $14.42 M(-1.1%) |
| Jun 2023 | - | $14.58 M(-13.4%) |
| Mar 2023 | - | $16.83 M(-27.5%) |
| Dec 2022 | $23.21 M(+164.4%) | $23.21 M(+50.7%) |
| Sep 2022 | - | $15.40 M(-5.4%) |
| Jun 2022 | - | $16.28 M(+27.6%) |
| Mar 2022 | - | $12.76 M(+45.3%) |
| Dec 2021 | $8.78 M(-27.8%) | $8.78 M(-22.7%) |
| Sep 2021 | - | $11.35 M(-11.8%) |
| Jun 2021 | - | $12.87 M(-0.3%) |
| Mar 2021 | - | $12.92 M(+6.2%) |
| Dec 2020 | $12.16 M(+70.4%) | $12.16 M(+23.7%) |
| Sep 2020 | - | $9.83 M(+6.3%) |
| Jun 2020 | - | $9.25 M(+4.9%) |
| Mar 2020 | - | $8.82 M(+23.6%) |
| Dec 2019 | $7.14 M | $7.14 M(+7.6%) |
| Sep 2019 | - | $6.63 M(+8.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $6.14 M(+11.5%) |
| Mar 2019 | - | $5.51 M(+20.7%) |
| Dec 2018 | $4.56 M(-47.3%) | $4.56 M(-3.8%) |
| Sep 2018 | - | $4.74 M(+15.5%) |
| Jun 2018 | - | $4.11 M(-35.2%) |
| Mar 2018 | - | $6.34 M(-26.8%) |
| Dec 2017 | $8.66 M(+33.3%) | $8.66 M(-9.9%) |
| Sep 2017 | - | $9.61 M(+24.3%) |
| Jun 2017 | - | $7.73 M(+1.7%) |
| Mar 2017 | - | $7.61 M(+17.2%) |
| Dec 2016 | $6.49 M(-3.3%) | $6.49 M(+6.5%) |
| Sep 2016 | - | $6.10 M(+5.8%) |
| Jun 2016 | - | $5.76 M(-17.5%) |
| Mar 2016 | - | $6.99 M(+4.1%) |
| Dec 2015 | $6.71 M(-73.3%) | $6.71 M(+16.9%) |
| Sep 2015 | - | $5.74 M(+17.8%) |
| Jun 2015 | - | $4.88 M(-84.1%) |
| Mar 2015 | - | $30.61 M(+21.6%) |
| Dec 2014 | $25.17 M(+5740.3%) | $25.17 M(-0.4%) |
| Jun 2014 | - | $25.27 M(+3245.5%) |
| Mar 2014 | - | $755.40 K |
| Dec 2013 | $431.00 K(+308.9%) | - |
| Dec 2012 | $105.40 K | - |
FAQ
- What is Viking Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Viking Therapeutics?
- What is Viking Therapeutics annual total liabilities year-on-year change?
- What is Viking Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Viking Therapeutics?
- What is Viking Therapeutics quarterly total liabilities year-on-year change?
What is Viking Therapeutics annual total liabilities?
The current annual total liabilities of VKTX is $28.04 M
What is the all time high annual total liabilities for Viking Therapeutics?
Viking Therapeutics all-time high annual total liabilities is $28.04 M
What is Viking Therapeutics annual total liabilities year-on-year change?
Over the past year, VKTX annual total liabilities has changed by +$7.97 M (+39.72%)
What is Viking Therapeutics quarterly total liabilities?
The current quarterly total liabilities of VKTX is $28.04 M
What is the all time high quarterly total liabilities for Viking Therapeutics?
Viking Therapeutics all-time high quarterly total liabilities is $33.63 M
What is Viking Therapeutics quarterly total liabilities year-on-year change?
Over the past year, VKTX quarterly total liabilities has changed by $0.00 (0.00%)